{"id":"W4288458053","doi":"10.1016/s0140-6736(22)01212-0","title":"Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis (SELECT-AXIS 2): a randomised, double-blind, placebo-controlled, phase 3 trial","year":2022,"lang":"en","type":"article","venue":"The Lancet","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Placebo; Ankylosing spondylitis; Clinical endpoint; Internal medicine; Axial spondyloarthritis; Randomized controlled trial; C-reactive protein; Clinical trial; Physical therapy; Surgery; Pathology; Inflammation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001763167,0.002086125,0.00400653,0.0004263684,0.000471966,0.001415137,0.0009477766,0.00275037,0.008280576],"category_scores_gemma":[0.001748905,0.0005818196,0.003450743,0.0005505363,0.0009990894,0.001180753,0.0004137367,0.003682754,0.001290941],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008354508,"about_ca_system_score_gemma":0.001069846,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00151544,"about_ca_topic_score_gemma":0.003893478,"domain_scores_codex":[0.9994569,0.0002509944,0.00003524662,0.00008960524,0.00004759747,0.0001196386],"domain_scores_gemma":[0.9993142,0.0002425207,0.0001484992,0.00004345981,0.00005777086,0.0001935195],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9753388,0.001560414,0.0002598548,0.002512092,0.002130825,0.00006225425,0.00004365721,0.0002329545,0.001381871,0.0001844643,0.002334592,0.01395814],"study_design_scores_gemma":[0.9849296,0.0127077,0.0006013574,0.00008926415,0.000606189,0.00003926838,0.0000162532,0.000111834,0.0001094854,0.0001149523,0.0006635014,0.00001061067],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8906561,0.07964001,0.002099549,0.003376244,0.003941499,0.007186255,0.004953613,0.0004411279,0.007705629],"genre_scores_gemma":[0.949216,0.02506294,0.002273725,0.004455428,0.001402772,0.006808625,0.003006845,0.00005549694,0.00771809],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008280576,"threshold_uncertainty_score":0.02770126,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0484367491958833,"score_gpt":0.3323955849101334,"score_spread":0.2839588357142501,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}